Quantum Cyber N.V.

QUCY ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $537.1K $894.0K $895.5K $529.9K $577.3K $493.6K $281.4K
Cost of Revenue $147.3K $319.1K
Gross Profit $389.8K $574.9K
Gross Margin 72.6% 64.3%
Operating Expenses
Research & Development $4.9M $5.7M
SG&A Expense $5.1M $6.7M
Operating Income $-16.1M $-18.8M $-26.6M $-26.4M $-9.7M $-673.7K $-921.9K
Operating Margin -3,005.0% -2,099.9% -2,975.5% -4,990.6% -1,684.4% -136.5% -327.6%
Interest Expense $1.0M $522.4K $242.0K $339.2K $176.4K $156.9K
Pretax Income $-16.2M $-21.6M $-26.3M $-26.4M $-11.7M $-586.9K $-957.1K
Income Tax Expense
Net Income $-16.2M $-21.6M $-26.3M $-26.4M $-11.7M $-586.9K $-957.1K
Net Margin -3,018.3% -2,416.0% -2,941.9% -4,979.9% -2,024.8% -118.9% -340.1%
EPS (Basic) $-2.70 $-3.65 $-10.79 $-12.43 $-0.27 $-0.02 $-0.03
EPS (Diluted) $-2.70 $-3.65 $-10.79 $-12.43 $-0.27 $-0.02
Shares Outstanding (Basic) 6.0M 5.9M 127.0M 87.8M
Shares Outstanding (Diluted) 6.0M 5.9M 127.0M 87.8M
Dividends Per Share